Pharmaxis has announced
“significant headline results” for the
first stage of an international Phase
III trial of Bronchitrol (inhaled
mannitol) in patients with cystic
fibrosis.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 17 May 14 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 May 14
A PHARMACIST facing charges of sexual assaulting a patient will be allowed to practice after an NSW Civil and Administrative Tribunal overturned a suspension handed down by the Pharmacy Council of NSW in Aug.